News & Updates
Filter by Specialty:
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients
All intravenous (IV) and subcutaneous (SC) doses of the monoclonal antibody combination of casirivimab plus imdevimab effectively reduces viral load in COVID-19 patients with asymptomatic or low-risk symptomatic infection, according to the results of a phase II study.
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients
07 Sep 2022Dietary cholesterol consumption may lead to subsequent type 2 diabetes
There appears to be a positive dose-response association between dietary cholesterol and type 2 diabetes mellitus (T2DM), where the higher the intake, the greater the incidence of T2DM especially in Western countries, according to a study.
Dietary cholesterol consumption may lead to subsequent type 2 diabetes
07 Sep 2022Topical combination, physical treatments best for mild-to-moderate acne
Topical pharmacological treatment combinations, chemical peels, and photochemical therapy are deemed to be the best and the most effective options for mild-to-moderate acne vulgaris.
Topical combination, physical treatments best for mild-to-moderate acne
06 Sep 2022Regular coffee intake ups risk of primary open-angle glaucoma
Genetic evidence from a recent study suggests that habitual coffee drinkers have an increased risk of primary open-angle glaucoma (POAG).
Regular coffee intake ups risk of primary open-angle glaucoma
06 Sep 2022Poor patients with heart failure at higher risk of readmission
In residential neighbourhoods, patients with heart failure (HF) living in high poverty are more likely to be readmitted to hospitals, a recent study has found. The high rates of hypertension and diabetes in these areas partly explain the effect of high poverty.